MeSH tree: C19.344.894
Stopping the widespread use of unnecessary, potentially even harmful, cancer screenings can take up to 13 years and potentially even longer after new guidelines are put in place, according to a new study published in BMJ ...
Jun 9, 2025
0
21
Carnegie Mellon University researchers are using personalized models to decode how cancer behaves in individual patients—revealing hidden subtypes, improving survival predictions and charting a new course for precision medicine.
May 29, 2025
0
17
Globally, women are roughly twice as likely as men to be diagnosed with thyroid cancer. However, recent research shows that men face an equal risk. Mayo Clinic experts say that men and women alike should be aware of thyroid ...
May 27, 2025
0
18
Telling the difference between benign and cancerous thyroid nodules before surgery is notoriously challenging, but a new study finds that a combination of artificial intelligence and data analysis techniques may yield surprisingly ...
May 6, 2025
0
17
Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment. According to new research published in ...
Apr 25, 2025
0
25
An interdisciplinary research team has unveiled the world's first artificial intelligence (AI) model designed to classify both the cancer stage and risk category of thyroid cancer, achieving impressive accuracy exceeding ...
Apr 23, 2025
0
43
A new study led by researchers at Yale University published in Environmental Health Perspectives, suggests that early-life exposure to two widespread environmental pollutants—small particle air pollution and outdoor artificial ...
Apr 16, 2025
0
15
Helene Lindfors, Ph.D. Student at the Endocrine Surgery research group, the Department of Molecular Medicine and Surgery, will defend her thesis "Tumor burden, thyroglobulin and Ki-67 as prognostic indicators in papillary ...
Mar 27, 2025
0
17
Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb. 5 in The Lancet Diabetes & Endocrinology.
Feb 12, 2025
0
9
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a study published online ...
Jan 30, 2025
0
24
